Evolocumab Plus Ezetimibe in High Risk Haemodialized Statin Intolerant Patients

Conditions:   Hypercholesterolemia;   Chronic Kidney Disease Requiring Chronic Dialysis Interventions:   Drug: Evolocumab + ezetimibe;   Drug: Placebo + ezetimibe Sponsors:   Policlinico Casilino ASL RMB;   IRCCS San Raffaele Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials